A trial of arbidol hydrochloride in adults with COVID-19

BACKGROUND: To date, there is no effective medicine to treat coronavirus disease 2019 (COVID-19), and the antiviral efficacy of arbidol in the treatment for COVID-19 remained equivocal and controversial. The purpose of this study was to evaluate the efficacy and safety of arbidol tablets in the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jingya, Zhang, Jinnong, Jin, Yang, Tang, Zhouping, Hu, Ke, Sun, Hui, Shi, Mengmeng, Yang, Qingyuan, Gu, Peiyu, Guo, Hongrong, Li, Qi, Zhang, Haiying, Li, Chenghong, Yang, Ming, Xiong, Nian, Dong, Xuan, Xu, Juanjuan, Lin, Fan, Wang, Tao, Yang, Chao, Huang, Bo, Zhang, Jingyi, Chen, Shi, He, Qiong, Zhou, Min, Qu, Jieming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532042/
https://www.ncbi.nlm.nih.gov/pubmed/35830201
http://dx.doi.org/10.1097/CM9.0000000000002104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532042/
https://www.ncbi.nlm.nih.gov/pubmed/35830201
http://dx.doi.org/10.1097/CM9.0000000000002104

Ejemplares similares